Home » today » Health » J&J, Biontech, Moderna, Novavax … One year after the announcement of the Covid-19 vaccine

J&J, Biontech, Moderna, Novavax … One year after the announcement of the Covid-19 vaccine

It has been practically a year since announcement of the first vaccine against Covid-19 and in the analysis we see some of the most important pharmaceutical companies. We start with Johnson & Johnson, owner of Janssen, which is currently a bullish action and has undergone a certain correction that may be the perfect excuse to think about riding the bottom trend.

BIONTECH and MODERN They are in a situation similar to J&J, in which we see a strong correction from the highs zone. We end the analysis with NOVAVAX In the absence of marketing your product, we see a much more erratic behavior than the previous ones, but which is in the support zone. As always, all levels and structures are explained in detail in the video

– .

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.